Vi gør digitale koncepter til virkelighed.Specialister i at bygge og drive brandsVi er en flok tech-nørder med stor erfaring i udviklingen af successfulde digitale produkter. Ambitionerne er store og vi arbejder aktivt på vores næste store koncept - en social datingapp - som snart lanceres på det danske marked. Læs mere på: www.amsiq.com PASSIONEREDE TECH-NØRDERVi er et ambitiøst og ungt softwarehus med alle kompetencerne til at udvikle, bygge og brande digitale koncepter.Med vores iværksætter-state-of-mind løfter vi i fællesskab, og arbejder hen imod at blive trendsættere i den digitale verden, med vores værdiskabende produkter.Udvikling og innovation driver os til at flytte grænser for det teknisk mulige, og for at skabe de bedste løsninger for vores brugere. Derfor arbejder vi ikke med deadlines, men har fuld fokus på kvalitet!Vores arbejdsfilosofi er en afbalanceret blanding af teknisk-nørderi, passion for mennesker, masser af samarbejde og highfives 🙏

Saninudge is a healthcare technology company, our mission is to eliminate Hospital Acquired Infections, a leading cause of death in the entire world. We design and market the only comprehensive hand-hygiene performance system which combines sensor networks with nudging technology to provide a complete, long-term and cost-effective hand hygiene system for healthcare institutions. You should apply for a job at Sani nudge if you want to have a job in a fast moving, intense company with the smartest people in the healthcare industry. We focus on reducing stress and improve quality of experience for all working on the project. Company facts We have more than 5,000 active sensors installed in hospitals. They have registered +2,000,000 hand sanitations and +100,000 patient interactions. They help +1,000 healthcare workers ensure proper hand hygiene compliance. We help hospitals and nursing homes in 7 European countries have clean hand when treating patients. We work with the largest healthcare companies in the world

Who's Penneo? Before telling you who we are and what we do, let us say that the most important asset at Penneo is our PEOPLE. Our workplace culture is open, inclusive, respectful and driven by the mindset that we are all one big family and we should treat each other as such. For that reason, we are not simply looking for new employees, we are looking to form new long-term relationships with people that can resonate with our values. These include vulnerability, responsibility, transparency, alignment, agility, bravery and unity. Penneo strives to make work fun and succeed in our people waking up in the morning and being excited about coming to the office, which is why we want all Penneos to work for a mission, not for a workplace. Our mission is to help businesses manage and automate their digital document and signing workflows in a fast, streamlined and effortless way, while at the same time allow them to be fully compliant and secure, thus tackling today’s compliance and security challenges. In addition, we want to contribute to building a more environmentally friendly world, by making businesses go paperless! Starting back in 2014, Penneo is now a hyper growth SaaS company of 50 colleagues and growing, working with more than 1600 customers in the Nordic Region. Already we work with companies such as Deloitte, KPMG, EY, PwC and our client base is rapidly expanding!

Connected Cars is building the most compelling ecosystem for mobility innovation, connecting millions of users and hundreds of organizations, all based on the largest and broadest data-set from cars in the world. Our mission is to enable safer, more sustainable and convenient mobility, through responsible and transparent collection and sharing of data. The Connected Cars solution provides intelligent and effective monitoring of vehicles for workshops and fleet managers, as well as a better driving and service experience for car owners. Our team consists of people with backgrounds from strategy, tech, automotive, and financial services. Some of us have successful startup experience, many of us like the latest technologies and while we differ in profiles and personalities, all of us believe in team effort, fun at work, and relentless execution. Connected Cars is fully funded by Semler Gruppen and operates autonomously.

Pinstriped is a powerful SaaS product which has just launched from Beta, already has paying users and with numbers growing daily. We currently have a macOS app and are building out a web app.We make it easy for the person calling the meeting to take ownership, prepare an agenda and ensure the meeting is decision-focused, instead of discussion-focused. Pinstriped is your easy way to prepare and run successful meetings

Loyalty Key offers loyalty solutions tailored to the individual needs of companies to strengthen and enhance the relationship between the customers and company. We are represented in Denmark, Sweden and Norway.       Our objective is clear: to be innovative within the field of concept development and management of benefit services. We want to be first movers in the loyalty market, and to constantly be abreast of the end user’s wants and needs – even before they become aware of them!

Add a description between 300 and 4000 characters Add a description between 300 and 4000 characters Add a description between 300 and 4000 characters Add a description between 300 and 4000 characters Add a description between 300 and 4000 characters Add a description between 300 and 4000 characters

At LifeBoard ApS we are designing the new generation of public rescue equipment, a rescue board, that makes a difference. The LifeBoard® ensures that beachgoers as civil rescuers have the necessary tool at hand to safely stabilize an accidents out in the water. We want to increase water safety on beaches by analyzing and customize safety solution with theLifeBoard®. With the LifeBoard® surfboardlooking design it is easier for civil beachgoers to use compared to the lifebuoy ring. The ring is not designed to be used for swimming rescues, but to be thrown from harbors, piers and boats. The lifebuoy ring is considered inefficient on flat beaches, where it is rarely used successfully. The aim with the LifeBoard® is to avoid civil rescuers from becoming a victim in the at- tempt of rescueing another and to decrease swimming-related fatal drownings by 50%. With the LifeBoard® civil rescuers can reach a distressed faster and safer. Safety to avoid a fatal drowning of the civil rescues and/or victims. Fast to save the victim before it is too late, since a drowning can happen in less than 60 sec and reducing the risk of permanent injuries and hospitalisation of near-drowning victims. If you are interested in water safety or becoming a part of our journey, don’t hesitate to contact us 😊🤙

Reduced is an innovative food production company. We specialize in creating high-quality food products made from excess produce. Our mission is to reduce food waste by using vegetables, protein and other nutritional sources leftover from the conventional food industry. Right now, we put all our time and effort into creating sustainable stock. We aim to develop a broad portfolio of products that will replace conventional choices. Always with a focus on taste and sustainability. In 6 months we have developed and launch four products based on excess produce, without seeking any financing. The products are sold in 55 supermarkets (Irma, SuperBrugsen, Meyers Deli etc), at Nemlig.com and in food service. The products are developed with one thing in mind: "How can we make taste from waste?". These are the four products: 1) Organic Chicken Stock: Made from egglaying chickens in excess from egg production. The chickens usually are used for biogas. We are changing this. 2) Shellfish Stock: Made from some of the 12 billion shore crabs in the Danish seas. Shore crabs are a massive problem for fishermen and they harm marine ecosystems. 3) Organic Vegetable Stock: Made from nordic seaweed and fragments of dried mushrooms. Seaweed is considered as one of the most overseen and essential resources of future food. 4) Organic Veal Stock: Made from bull calf bones in excess from milk production. There is little demand for bull calf bones. We strive to change the value chain. We now have a proven product-market fit and are looking into scaling our operation.

Mendonca Biomed is an early stage life science startup with the aim to develop and validate novel biomarker for the early detection of viral infections in blood with an affordable yet simple detection method that can be universally applied. The company was originally founded by myself Kevin Mendonca in India based on his 15 years of accumulative research knowledge. Preliminary data on the utility of viral miRNA biomarkers for the screening of blood for transfusion transmitted viral infections, which are potentially superior to the currently available markers, and a simplified assay that is cost effective and can be universally adapted, were developed in India. However, due to an innate lack of infrastructure and funding opportunities in India, I applied for the startup Denmark program to move the company to the medicon valley. I recently moved to Demark, registered a privately owned company and currently in pursue of funding to validate the viral miRNA biomarkers for the early detection of HIV, HBV and HCV in donated blood. Around the world, more than 92 million blood donations are collected every year. Screening of donated blood and derived products, for HIV, HBV and HCV is mandatory worldwide. Screening is a key safety measure in protecting recipients from transfusion transmitted infections, especially in developing nations in Africa and Asia, where the donated blood is not processed because of high costs and lack of infrastructure. Moreover, in emergency situation like natural calamities, disasters and sudden outbreaks, the currently available methods are inadequate for on-site screening. Serological testing (antigen and antibody detection assays) have historically been the foundation of blood screening but with huge drawbacks of long window periods. Newer strategies like the PCR based amplification viral genomic DNA/RNA in blood have helped shorten the window period but have not eliminated it. PCR assays have also been known to fail in low viremia and/or suboptimal amplification efficiency. They are far more expensive than the serological assay, requires expertise, specialized equipment and a molecular biology setup, which is not available in the resource poor settings of the developing countries. Our solution is to develop and validate novel viral miRNA biomarkers that have the potential to further reduce the window period and use the unique characteristics of these biomarkers to develop a simple, multiplex (3 in 1), inexpensive probe hybridization assay that can be universally utilized in all settings and conditions. Viral miRNA molecules are easy to validate as biomarkers since the presence of vmiRNA’s is a definite indicator of infected cells. Benefit: Multiplex 3 in 1 test. Method as simple to perform as the serological assay with the benefits of a molecular assay. Can be adapted in any setting, even in the field and low resource conditions in developing nations. Potentially, lower window period of detection compared to any biomarkers that are available in the market currently. Value: High throughput, lower turnover time with lower chances of human error. Advantages of a molecular assay with the simplicity and affordability of a serological assay. Does not require specialized setup, infrastructure and highly trained technicians. Potentially, could detect the infections faster than any other tests in the market, lowering the risk of transfusion transmission. Once this platform has been validated, the product line can be expanded to cover all commercially viable viral infections. A HPV assay based on this platform, for example, could be a potential replacement for the invasive PAP test, and can be performed during a routine blood test. The platform can be further adapted to screen for novel viral infections like SARS, MERS, ZIKA etc. It can be also be developed to screen and control other sporadic outbreaks the like Dengue, Chikungunya etc.

For a quick intro pls see: https://drive.google.com/file/d/168TTZsNef43Awmxz3iALMhx2saVk5ihe/view?usp=sharing The problem & the idea Data may be the driver for change, improvement and understanding, in many sectors, amongst these also healthcare. Patient data is an important creator of knowledge both on an individual level but also on a group, regional or country level. On an individual level, patient data may support and build the clinical decisions, it may provide more efficient treatment, both in regard to time and economy and secure that knowledge about the individual is transferred fast and unbiased to the healthcare staff. For the patient, sharing of his/her data will secure a better understanding of the needs and support better diagnosis and treatment. Patient data are collected and noticed in some form in most countries, either on paper or electronically. Many countries have some sort of an electronic patient journal, either on a country level, regionally or locally. However, many countries also still use pen & paper. This challenges the storage and continuity of data collection and transfer. Patient data records in electronic form reduces the risk of losing valuable data but also allows the data to be shared if needed. The acknowledgement of the importance on several levels of having patient data and the absence of a central, regional or local electronic patient data recording system in Sub-saharan African countries (the target region) initiated the idea of looking at how it would be possible to collect and make patient data readily available for treatment, benefitting both patient and caregiver, and in a bigger perspective, for research and strategic healthcare initiative planning. During small initial market and possibility investigations the idea of creating a patient owned electronic healthdata journal app arose. Mobiletechnology is both greatly advantaged and outspread in the target region and the number of mobile consumers are increasing every year. It was and is anticipated, that the possibility of having a central system is, due to structural and financial reasons, not a possibility but to empower the patient with the ownership of own data through an app seemed a possibility. It is important to underline that data must be generated from the healthcare provider and then fed into the patientjournal at the site of the consultation. The idea is to have the most relevant data collected and stored in the app, ie. medication, allergies, blood type, diagnosis and immunizations. The data that will go into the app is transferred from a healthcare provider at the site of the healthcare visit, eg a clinique, hospital, other. That means that the healthcare provider must have access to a tablet or smartphone containing the healthcare provider app which connects to the patients healthcare data app at the visit. Also any healthcare provider with the app will followingly get access to the data from the patient by connecting (and by being given access by the patient) to get patients healthdata app. So, in summary the basic idea is to provide all citizens with a tool that will help them keep track of their most important healthcare related data including completed and planned treatments, diagnosis, tests, allergies etc. The idea is further that the data is owned by the citizens/patients, and not by the non-existing national or any hospital specific system. Upon each contact with the healthcare personnel the patient's information is updated by the healthcare personnel (e.g. symptoms, diagnosis, tests, treatment, next visit etc.) The basic idea/assumption is that no national healthcare system will be developed in near or short-term future, and that a personally owned "electronic patient journal" can have a significant positive impact on the quality of treatments because of a more complete picture of the patient is available at the time, when a diagnosis and treatment is to be decided.

NUKIGA faciliterer værdiskabende partnerskaber mellem iværksættere, virksomheder og studerende. Vi udvikler et virtuelt væksthus, og vi skaber ny viden om Grønland i Danmark gennem en række kulturelle projekter. Dialog og partnerskaber opstår, når mennesker mødes enten fysisk eller online. Vores arbejde er derfor funderet i både fysiske såvel som online events og projekter.

Mads Olesen Holdings is owned by entrepreneur Mads Andreas Olesen. After selling his first companies for more than 100 mio. kroner, he now invests in startups, real estate and more through Mads Olesen Holdings (CVR: 36917997) and subsidiaries. In 2020, Mads Olesen Holdings invested in more than 50 ecommerce businesses through its investment in MXNEY.io, that specializes in alternative ecommerce funding. In 2021, the holding company is looking to add 10 properties to its current portfolio of 19 rental properties.

We create a future where the entire water infrastructure can be monitored in real-time using a network of distributed wireless sensors. Dryp is a range of solutions that enable proactive and holistic decision-making for water infrastructure. Dryp builds data bridges across both physical and adminstrative boarders. We are uniquely co-owned by a major danish utility - along with private companies and investors. We are spearheading a data, iot and machine-learning revolution.

Our mission is to provide functionally validated, personalised healthcare solutions to address unmet needs within cognitive disorders and obesity. Our journey is part of a healthcare evolution away from symptom-based, one-fits-all medicine, and towards personalised, causality-driven solutions with systemic efficacy - with the aim to address major global disease challenges in a more targeted, natural manner. Metaceutic ApS develops plant-based health-enhancing dietary food supplements that are functionally validated to predictably alter specific parts of the gut microbiota in order to enhance cognitive function regarding mental stress remedy, appetite regulation, and general cognitive enhancement.